Unilever
UL | NYSE
$66.44
+$1.18 (+1.81%)
At close: Nov 2, 2026, 4:00 PM ET
$66.44
$0.00 (0.00%)
After-hours:
Nov 2, 2026, 4:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 4.73B | 3.94B | 4.34B | 6.14B | 4.97B | 4.16B | 4.99B | 4.33B | 5.41B | 3.42B | 4.18B |
Short-Term Investments | 1.15B | 1.12B | 966M | 1.49B | 896M | 1.73B | 1.34B | 1.2B | 1.17B | 1.08B | 845M |
Long-Term Investments | 3.32B | 3.06B | 1.4B | 618M | 1.29B | 1.87B | -379M | -293M | -140M | -91M | -24M |
Other Long-Term Assets | 5.71B | 5.44B | 5.32B | 6.71B | 6.12B | 4.18B | 6.8B | 6.65B | 9.03B | 7.38B | 6.03B |
Receivables | 10.2B | 7.67B | 7.69B | 5.12B | 7.93B | 4.94B | 8.05B | 7.46B | 7.31B | 4.47B | 6.48B |
Inventory | 4.52B | 4.04B | 5.5B | 5.18B | 5.62B | 5.12B | 5.67B | 5.93B | 5.89B | 4.68B | 4.77B |
Other Current Assets | 795M | 285.88M | 687M | 689M | 883M | 1.21B | 308M | 7.7B | 3.42B | 3.26B | 1.14B |
Total Current Assets | 21.39B | 17.06B | 19.19B | 19.19B | 20.22B | 17.89B | 20.36B | 19.16B | 23.2B | 17.4B | 17.41B |
Property-Plant & Equipment | 9.36B | 8.99B | 10.94B | 11.67B | 11.1B | 10.7B | 10.59B | 10.77B | 10.73B | 10.35B | 10.52B |
Goodwill & Intangibles | 36.08B | 34.75B | 38.04B | 40.9B | 41.1B | 39.47B | 39.96B | 40.49B | 40.51B | 38.59B | 35.3B |
Total Long-Term Assets | 55.54B | 53.38B | 56.81B | 60.56B | 59.61B | 57.33B | 58.05B | 58.66B | 61.69B | 57.69B | 53.15B |
Total Assets | 76.93B | 70.44B | 76B | 79.75B | 79.83B | 75.22B | 78.41B | 77.82B | 84.89B | 75.1B | 70.56B |
Account Payables | 19.31B | 16.93B | 16.3B | 10.26B | 17.21B | 10.36B | 17.37B | 11.1B | 17.15B | 8.9B | 14.8B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 850.5M | -6.71B | n/a | -9.03B | 2.81B | -6.72B |
Short-Term Debt | 8.14B | 2.58B | 7.16B | 5.88B | 7.64B | 4.57B | 7.33B | 5.23B | 9.44B | 6.7B | 6.72B |
Other Current Liabilities | 529.36M | 701.7M | 744M | 2.4B | 557M | -311.34M | 7.35B | 6.27B | 10.46B | -1.72B | 672M |
Total Current Liabilities | 28.89B | 21.65B | 25.1B | 25.23B | 26.13B | 23.49B | 25.61B | 25.43B | 28.94B | 24.78B | 23.79B |
Long-Term Debt | 22.65B | 25.69B | 23.35B | 23.29B | 24.01B | 22.63B | 24.62B | 21.8B | 26.06B | 21.33B | 20.82B |
Other Long-Term Liabilities | 1.91B | 596.75M | 6.1B | 3.17B | 6.67B | 3.29B | 30.88B | 3.45B | 33.09B | 275M | 6.5B |
Total Long-Term Liabilities | 29.74B | 31.21B | 30.97B | 31.96B | 30.68B | 30.98B | 30.88B | 30.69B | 33.09B | 30.57B | 27.32B |
Total Liabilities | 58.63B | 52.86B | 56.07B | 57.2B | 56.81B | 54.47B | 56.49B | 56.12B | 62.03B | 55.35B | 51.11B |
Total Debt | 32.1B | 29.59B | 32.03B | 30.66B | 31.65B | 28.59B | 30.67B | 28.44B | 33.95B | 29.67B | 27.54B |
Book Value | 18.31B | 17.58B | 19.93B | 22.56B | 23.02B | 20.75B | 21.92B | 21.7B | 22.87B | 19.75B | 19.46B |
Book Value Per Share | 8.38 | 8.01 | 8.06 | 9.01 | 9.17 | 8.21 | 8.64 | 8.50 | 8.91 | 7.62 | 7.41 |
Common Stock | 85M | 84.96M | 88M | 88M | 88M | 87.95M | 92M | 92M | 92M | 92M | 92M |
Retained Earnings | 45.93B | 44.21B | 50.7B | 49.72B | 49.57B | 47.02B | 51.88B | 50.25B | 49.13B | 46.75B | 45.14B |
Comprehensive Income | -82.63B | -73.33B | -85.84B | -83.22B | -82.19B | -75.64B | -85.44B | -79.56B | -81.9B | -79.05B | -81.06B |
Shareholders Equity | 16.19B | 15.52B | 17.8B | 19.99B | 20.31B | 18.09B | 19.26B | 19.02B | 20.14B | 17.11B | 17.02B |
Total Investments | 4.64B | 4.18B | 2.36B | 2.11B | 2.19B | 3.6B | 961M | 904M | 1.03B | 989M | 821M |
Add to Watchlist
Select watchlists to add or remove UL